Werewolf Therapeutics
Cambridge
About Werewolf Therapeutics
Werewolf Therapeutics is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $178.2M
- Funding stage: IPO
- Last round: Post-IPO Secondary (May 2022)
- Ticker: nasdaq:HOWL
- Website: werewolftx.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/werewolf-therapeutics-42809 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.